Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003482 |
---|---|
Receipt number | R000004210 |
Scientific Title | A Phase I /II Study of Tri-weekly XELIRI with Bevacizumab for patient with Metastatic Colorectal Cancer as second-line chemotherapy. |
Date of disclosure of the study information | 2010/04/13 |
Last modified on | 2014/02/05 17:43:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/04/13 11:13:12 | ||
2 | Update | 2014/02/05 17:43:22 | Recruitment status Publication of results |